Pulse Biosciences Inc
Отворен
СекторЗдравеопазване
25.4 -2.79
Преглед
Промяна на цената на акция
24 ч
Минимум
25.26
Максимум
26
Приходи | -1.1M -19M |
|---|---|
Продажби | 137K 401K |
EPS | -0.241 |
Марж на печалбата | -4,633.666 |
Служители | 116 |
EBITDA | -1.4M -19M |
Препоръки | Купи |
|---|---|
12-месечна прогноза | +19.6% upside |
Следващи печалби | 11.08.2026 г. |
|---|
Пазарна капитализация | 179M 1.7B |
|---|---|
Предишно отваряне | 28.19 |
Предишно затваряне | 25.4 |
Настроения в новините
By Acuity
34%
66%
94 / 342 Класиране в Healthcare
Pulse Biosciences Inc Графика
Миналото представяне не гарантира бъдещи резултати.
Относно Pulse Biosciences Inc
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
